This compound is primarily utilized in the pharmaceutical industry as a chiral intermediate in the synthesis of active pharmaceutical ingredients (APIs). Its structure, featuring a difluorophenyl group, makes it valuable in the development of drugs targeting the central nervous system (CNS), particularly for conditions like depression, anxiety, and other psychiatric disorders. The chiral nature of the molecule allows for the production of enantiomerically pure compounds, which is crucial for ensuring the efficacy and safety of the final drug product. Additionally, its incorporation into drug molecules can enhance their pharmacokinetic properties, such as bioavailability and metabolic stability. Research also explores its potential use in creating novel therapeutic agents for neurological diseases due to its ability to interact with specific neurotransmitter systems.